Stockholders Equity (Details Narrative) - USD ($)		1 Months Ended		9 Months Ended
	Apr. 12, 2024	May 17, 2024	Jan. 17, 2024	Sep. 30, 2024
Warrants exercise price			$ 2.50
Replacement Warrants, outstanding			333,884
Salary for Equity Incentive Options [Member]
Issued stock options, value		$ 948,200
Exercise price		$ 2.50
Options vesting period		over twelve months
Issued stock options, shares		628,960
Issued options, term		10 years
Equity Cancel and Replacement Options [Member] | April 1, 2024 [Member]
Exercise price				$ 2.50
Options vesting period				over the three-year
Recognize stock compensation expense				$ 613,400
Committee Chairmans [Member]
Issued stock options, value				$ 5,200
Exercise price				$ 1.29
Issued stock options, shares				5,000
Issued options, term				10 years
Securities Purchase Agreement
Securities Purchase Agreement, Description			the Company sold an aggregate of 358,388 Units, comprising 358,388 shares of the Company’s common stock, par value $.05 per share (“Common Stock”) and warrants (“Warrants”) to purchase 358,388 shares of Common Stock for a total consideration of $716,776. The Company recognized $98,700 of issuance cost, which includes $71,100 attributable to legal and placement agent fees and $27,600 attributable to the fair value of warrants, issued to the placement agent, to purchase up to 17,919 shares of Common Stock at an exercise price of $2.00 per share on substantially the same terms as the Warrants issued to the purchasers of Units (“Investors”)
Board of Director Stock Options [Member]
Issued stock options, value	$ 34,500			$ 10,400
Exercise price	$ 1.75			$ 1.29
Options vesting period	over three years
Issued stock options, shares	25,000			10,000
Issued options, term				10 years